Solvay implements award-winning technology "pseudoliving" materials

Solvay Solexis announces today that it has started supplying a new grade of perfluoroelastomers created through its polymerization technology called “Branching & Pseudoliving”, which can generate products with properties that cannot be obtained by conventional manufacturing techniques. These high-value added materials are designed for sealing solutions in extreme environments. Their outstanding performance places them in the same pricing category as certain pharmaceutical products or precious metals. Compared with existing materials used to build fluid handling systems in critical processes, the new 'Tecnoflon' PFR 45HT perfluoroelastomer offers enhanced high temperature sealing, improved steam resistance, and excellent overall chemical resistance. The new perfluoroelastomer was developed as a tailor-made solution for specific, demanding applications. The Branching & Pseudoliving technology allows the creation of such complex, controlled macromolecular structures. While regular polymerization consists of the stepwise reproduction of a basic monomer molecule to create a simple linear structure, Branching & Pseudoliving is a molecular construction process that can be compared to the ‘growth’ of cells in living organisms. Bernard de Laguiche, Chief Executive Officer of Solvay Solexis noted. “This is a shining example of Solvay’s strategy aiming at ensuring sustainable, profitable growth through innovation and competitiveness.” Solvay Solexis’ Branching & Pseudoliving technology was distinguished by the Solvay Innovation Trophy (SIT), a contest aiming at rewarding new ideas which generate value for the Group and its stakeholders. 134 projects entered the last SIT contest, demonstrating the dynamism of the Group’s innovation strategy, and were scrutinized by a jury consisting of an equal number of in-house experts and prominent independent personalities. Solvay Solexis employs approximately 2,000 people and operates worldwide through seven companies in Italy, France, Japan, Brazil, China, Korea and the United States. The company is headquartered in Bollate (Milano, Italy), which also hosts its main R&D facility, with 300 researchers. More information from www.solvaysolexis.com. TS